Using Clinical Databases to Verify the Impact of Regulatory Agency Alerts in Japan: Hepatitis B Testing Behavior After an Alert Regarding Risk of Viral Reactivation

BACKGROUND: Measures of the effectiveness of risk minimization activities are necessary for the appropriate use of drugs, and clinical databases are a low-cost method of quickly producing such results. OBJECTIVE: The aim of this study was to explore the secondary application of clinical databases in...

Descripción completa

Detalles Bibliográficos
Autores principales: Udagawa, Yukio, Ohno, Shinya, Nakagawa, Shintaro, Sugimoto, Kazutaka, Mochizuki, Joji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883216/
https://www.ncbi.nlm.nih.gov/pubmed/27747569
http://dx.doi.org/10.1007/s40801-015-0034-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883216/
https://www.ncbi.nlm.nih.gov/pubmed/27747569
http://dx.doi.org/10.1007/s40801-015-0034-5

Ejemplares similares